WYMM Tour: Melbourne
Wednesday, 19th March 2025, 09:30 am - 04:45 pm AEDT - Melbourne, Australia (time subject to change)
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Wednesday, 19th March 2025, to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
We are also organising the Bioinformatics Workshop a day after this event. Click here for more information and register to attend.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Register
Agenda
09:30 am-16:45 pm AEDT | Agenda (subject to change) | Speaker |
|---|---|---|
09:30 - 10:20 | Registration/Breakfast | |
10:20 - 10:30 | Welcome | Tim Daykin, Oxford Nanopore Technologies |
10:30 - 11:00 | Methylation-based ctDNA detection with nanopore sequencing | Rodrigo Carlesi, Curtin Medical Research Institute, Curtin University |
11:00 - 11:30 | Advancing cancer research with Oxford Nanopore Technologies: improving structural variation and methylation detection | Marjan Neaini, Garvan Institute of Medical Research |
11:30 - 12:00 | Shining light on the pathogenic D4Z4 microsatellite (epi)genetics with nanopore sequencing | Quentin Gouil, Olivia Newton-John Cancer Research Institute |
12:00 - 13:15 | Networking Lunch | |
13:15 - 13:45 | ROBIN - Revolutionising brain tumour classification with real-time nanopore sequencing and adaptive sampling | Matt Loose, Deep Seq, School of Life Sciences, University of Nottingham |
13:45 - 14:15 | Investigating mRNA diversity in melanoma progression and therapy resistance | Lorey Smith, Peter MacCallum Cancer Centre and University of Melbourne |
14:15 - 14:45 | Case studies demonstrating impact of oxford nanopore sequencing in the context of rare disease diagnosis and gene discovery | Simon Sadedin, Murdoch Children's Research Institute |
14:45 - 15:15 | Networking break | |
15:15 - 15:45 | Developing a robust approach to determining plasmid transmission in the hospital setting | Jane Hawkey, Department of Infectious Diseases, School of Translational Medicine, Monash University |
15:45 - 16:15 | Developing an ICU respiratory metagenomic network for clinical care and pathogen surveillance | Jonathan Edgeworth, Department of Infectious Diseases, Guy’s & St Thomas Hospital |
16:15 - 16:35 | Oxford Nanopore: Technical updates | Rebecca Chesterfield, Oxford Nanopore Technologies |
16:35 - 16:45 | Closing | Ross Napoli, Oxford Nanopore Technologies |
Speakers
)
Methylation-based ctDNA Detection with Nanopore Sequencing
Rodrigo Carlessi, Curtin Medical Research Institute
Dr Rodrigo Carlessi is a Senior Research Fellow and the leader of the Cancer Genomics Group within t...
)
Advancing Cancer Research with Oxford Nanopore Technologies: Improving Structural Variation and Methylation Detection
Marjan Naeini, Garvan Institute of Medical Research
Dr. Naeini is a postdoctoral researcher in the Genomic Technologies Group at the Garvan Institute of...
)
Shining light on the pathogenic D4Z4 macrosatellite (epi)genetics with nanopore sequencing
Quentin Gouil, Olivia Newton-John Cancer Research Institute
Dr Gouil is an NHMRC Emerging Leadership fellow and lab head at the Olivia Newton-John Cancer Resear...
)
ROBIN - Revolutionising Brain Tumour Classification with Real-Time Nanopore Sequencing and Adaptive Sampling
Matthew Loose, University of Nottingham
Matt has been working on Nanopore sequencing since a long time ago. His group developed adaptive sam...
)
Investigating mRNA diversity in melanoma progression and therapy resistance
Lorey Smith, Peter MacCallum Cancer Centre
Dr Lorey Smith is a Mid-Career Victorian Cancer Agency Research fellow in Professor Grant McArthur’s...
Case Studies Demonstrating Impact of Oxford Nanopore Sequencing in the Context of Rare Disease Diagnosis and Gene Discovery
Simon Sadedin, Murdoch Children’s Research Institute
Dr Simon Sadedin is the Head of Clinical Bioinformatics at the Murdoch Children’s Research and Victo...
)
Developing a robust approach to determining plasmid transmission in the hospital setting
Jane Hawkey, Department of Infectious Diseases, School of Translational Medicine, Monash University and The Alfred Hospital
Jane is currently an NHMRC Emerging Leadership Fellow at Monash University, Melbourne, Australia. Sh...
)
Developing an ICU respiratory metagenomic network for clinical care and pathogen surveillance
Jonathan Edgeworth, Department of Infectious Diseases, Guy’s & St Thomas Hospital
Jonathan is a Consultant Microbiologist and Professor of Clinical Infectious Diseases at Guy's & St ...
)
Oxford Nanopore: Technical Updates
Rebecca Chesterfield, Oxford Nanopore Technologies
...
Oxford Nanopore Bioinformatics Workshop
Date: Thursday 20th March 2025
Time: 09:00 am - 03:30 pm (AEDT)
Venue: the InterContinental Melbourne the Rialto
There is no delegate fee for this workshop, but registration is required. Your place at this workshop will be confirmed via email.
Workshop Agenda
09:00 - 09:30 Registration
09:30 - 10:30 Introduction to Nanopore data & EPI2ME
10:30 - 10:45 Morning Tea
10:45 - 12:00 EPI2ME wf-transcriptomics hands on
12:00 - 13:00 Lunch
13:00 - 14:45 EPI2ME wf-human-variation hands on
14:45 - 15:30 Working Afternoon tea - Variant interpretation
15:30 - 15:45 Q&A
15:45 End